Related Experiment Video
Updated: Aug 10, 2026
08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Protective efficacy of pneumococcal polysaccharide vaccines
JAMA
|December 12, 1977
Summary
Pneumococcal vaccines significantly reduced pneumonia cases in South African gold miners. The 12-valent vaccine showed 92% efficacy, offering promising disease control.
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- Pneumococcal pneumonia poses a significant public health burden, particularly in vulnerable populations.
- Controlled clinical studies are essential for evaluating vaccine efficacy and safety.
Purpose of the Study:
- To assess the efficacy and safety of 6- and 12-valent pneumococcal capsular polysaccharide vaccines.
- To determine the reduction in laboratory-verified pneumococcal pneumonia cases.
Main Methods:
- Controlled clinical trials involving 1,523 participants receiving pneumococcal vaccine and 3,171 controls.
- Measurement of antibody development against vaccine-included capsular types.
- Laboratory verification of pneumococcal pneumonia cases.
Main Results:
- High antibody response observed in vaccine recipients against homologous pneumococcal types.
- A 76% reduction in pneumonia cases caused by homologous types with the 6-valent vaccine.
- A 92% reduction in pneumonia cases caused by homologous types with the 12-valent vaccine.
Conclusions:
- Pneumococcal polysaccharide vaccines are well-tolerated and effective in preventing pneumococcal pneumonia.
- The 12-valent vaccine demonstrated superior efficacy in this study population.
- These vaccines hold significant promise for the control of pneumococcal diseases.
More Related Videos
Related Concept Videos
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...